Aisyah Noor
Stock Analyst at Morgan Stanley
(2.97)
# 2,704
Out of 5,004 analysts
130
Total ratings
49.3%
Success rate
3.8%
Average return
Main Sectors:
Stocks Rated by Aisyah Noor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: TECN Tecan Group AG | Reiterated: Hold | CHF 160.00 → CHF 178.00 | CHF 223.20 | -20.25% | 18 | Sep 11, 2026 | |
| EPA: BIM bioMérieux S.A. | Reiterated: Sell | €64.00 → €66.00 | €77.70 | -15.06% | 10 | Sep 11, 2026 | |
| BIT: DIA DiaSorin S.p.A. | Reiterated: Hold | €60.00 → €71.00 | €78.80 | -9.90% | 17 | Sep 11, 2026 | |
| AMS: PHIA Koninklijke Philips N.V. | Reiterated: Hold | €25.00 → €22.00 | €21.87 | +0.59% | 5 | Sep 11, 2026 | |
| QGEN Qiagen | Reiterated: Buy | $46 → $48 | $44.18 | +8.14% | 24 | Sep 11, 2026 | |
| LON: CTEC Convatec Group PLC | Reiterated: Buy | 270p → 289p | 209p | +38.01% | 5 | Sep 2, 2026 | |
| LON: SN Smith & Nephew plc | Downgraded: Hold | 1,304p → 1,158p | 1,008p | +14.88% | 7 | Sep 2, 2026 | |
| ETR: FRE Fresenius SE & Co. KGaA | Reiterated: Buy | €49.00 → €52.00 | €46.15 | +12.68% | 6 | Aug 10, 2026 | |
| ETR: FME Fresenius Medical Care AG | Reiterated: Sell | €32.00 → €31.00 | €39.80 | -22.11% | 7 | Aug 5, 2026 | |
| SWX: STMN Straumann Holding AG | Reiterated: Sell | CHF 81.00 → CHF 85.00 | CHF 97.48 | -12.80% | 5 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | CHF 172.00 → CHF 205.00 | CHF 241.00 | -14.94% | 2 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €41.00 → €37.00 | €37.79 | -2.09% | 4 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 159.00 → CHF 161.00 | CHF 114.00 | n/a | 7 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | kr 182.00 → kr 175.00 | kr 242.90 | n/a | 3 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 22.00 → CHF 20.00 | CHF 11.44 | n/a | 8 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €140.00 → €147.00 | €60.50 | n/a | 2 | Mar 12, 2025 |
Tecan Group AG
Sep 11, 2026
Reiterated: Hold
Price Target: CHF 160.00 → CHF 178.00
Current: CHF 223.20
Upside: -20.25%
bioMérieux S.A.
Sep 11, 2026
Reiterated: Sell
Price Target: €64.00 → €66.00
Current: €77.70
Upside: -15.06%
DiaSorin S.p.A.
Sep 11, 2026
Reiterated: Hold
Price Target: €60.00 → €71.00
Current: €78.80
Upside: -9.90%
Koninklijke Philips N.V.
Sep 11, 2026
Reiterated: Hold
Price Target: €25.00 → €22.00
Current: €21.87
Upside: +0.59%
Qiagen
Sep 11, 2026
Reiterated: Buy
Price Target: $46 → $48
Current: $44.18
Upside: +8.14%
Convatec Group PLC
Sep 2, 2026
Reiterated: Buy
Price Target: 270p → 289p
Current: 209p
Upside: +38.01%
Smith & Nephew plc
Sep 2, 2026
Downgraded: Hold
Price Target: 1,304p → 1,158p
Current: 1,008p
Upside: +14.88%
Fresenius SE & Co. KGaA
Aug 10, 2026
Reiterated: Buy
Price Target: €49.00 → €52.00
Current: €46.15
Upside: +12.68%
Fresenius Medical Care AG
Aug 5, 2026
Reiterated: Sell
Price Target: €32.00 → €31.00
Current: €39.80
Upside: -22.11%
Straumann Holding AG
Jun 30, 2026
Reiterated: Sell
Price Target: CHF 81.00 → CHF 85.00
Current: CHF 97.48
Upside: -12.80%
Jun 23, 2026
Upgraded: Hold
Price Target: CHF 172.00 → CHF 205.00
Current: CHF 241.00
Upside: -14.94%
Jun 23, 2026
Reiterated: Hold
Price Target: €41.00 → €37.00
Current: €37.79
Upside: -2.09%
Sep 9, 2025
Reiterated: Buy
Price Target: CHF 159.00 → CHF 161.00
Current: CHF 114.00
Upside: n/a
Jul 23, 2025
Reiterated: Hold
Price Target: kr 182.00 → kr 175.00
Current: kr 242.90
Upside: n/a
Mar 18, 2025
Reiterated: Hold
Price Target: CHF 22.00 → CHF 20.00
Current: CHF 11.44
Upside: n/a
Mar 12, 2025
Reiterated: Hold
Price Target: €140.00 → €147.00
Current: €60.50
Upside: n/a